Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Medications originally created to manage type 2 diabetes are now making headlines for their surprising impact on weight loss
Medical Considerations: Semaglutide or Tirzepatide, including micro-dose programs, cannot be prescribed and should not be purchased by individuals with a BMI under 25 (or under 20 for micro-dosing), an eating disorder, diabetes, gallbladder disease, history of drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer or a family history of it, diabetic retinopathy, multiple endocrine neoplasia type 2, or those who are pregnant, breastfeeding, or planning to become pregnant
At study entry, patients in study 1 were not treated with oral antihyperglycemic agents
This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (20590808, T Ito) and the Research Committee provided by the Ministry of Health, Labour, and Welfare Japan (50253448, T Ito)
Existen varios estudios publicados al respecto de baja calidad, casos controles, retrospectivos y algn estudio aleatorizado exploratorio prueba de concepto913
